Corporate strategy

A strong and growing position on the parenteral market

The parenteral market is growing due to worldwide rise in general healthcare consumption and increasing development for complex diseases areas. SGD Pharma focuses its investment to support this dynamic market on mature and emerging zones :

  • To widen its product offer, SGD Pharma enters into the tubular glass market through external growth.
  • SGD Pharma strengthens its capabilities in pharmaceutical glass containers for injectable and infusion markets
  • The R&D department imagines solutions easy-to-use in the new pharmaceutical facility format: Smaller-scale, flexible and multiproduct, these facilities use single-use technologies, continuous processing and modular design.

A global and patient-oriented player in the pharmaceutical primary packaging

SGD Pharma, Inspiring confidence.

With a global footprint and a strong sales force, SGD Pharma is recognised worldwide as a key player that customers can rely on to support new product development, day-to-day delivery, quality or regulatory support.

SGD Pharma benefits from a long know-how and a best-in-class manufacturing footprint. The company has a long-term investment plan to regularly leverage its manufacturing facilities and develop people competencies to be at the cutting edge of the technology. SGD Pharma commits to have the same standard in all its facilities. In 2016, all plants are certified according to ISO 15378 standard, pharma GMP’s compliant and equipped with ISO 8 clean rooms.

To succeed in its ambition, SGD Pharma relies on fundamental values shared with its employees.

COMMITMENT : Commitment is a key value for SGD Pharma and includes responsibility towards customers and patients ; employees ; society.

INNOVATION : SGD Pharma is recognised as an innovative leader in glass for pharmaceutical primary packaging. The company dedicates important resources to be one-step beyond, answer customers expectations and commit with patient safety.

SAFETY : Safety is a major priority for SGD Pharma. Best practices, preventive and corrective actions, are implemented daily to continuously protect employees’ health.

DEVELOP TALENT : SGD Pharma commits to constantly train its employees and offer them career opportunities within the company.

Group Executive Committee

Jürgen Sackhoff

CEO

Read more


Laurent Zuber

CCO

Read more

Christophe Muguet

COO

Read more


Jean-jacques Bancel

CFO

Read more

Pierre-michel Bataillard

CHRO

Read more